Samsara BioCapital, L.P. - 18 Nov 2024 SCHEDULE 13D/A Report for Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (SYRS)

Filing Manager
Samsara BioCapital, L.P.
Reporting Manager
Samsara BioCapital, L.P.
Security
Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value per share
Symbol
SYRS
Shares outstanding
27,196,692 shares
Disclosed Ownership
707,114 shares
Ownership
2.6%
Form type
SCHEDULE 13D/A
Filing time
27 Mar 2025, 18:17:04 UTC
Date of event
18 Nov 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Samsara BioCapital, L.P. 2.6% 707,114 0 707,114 /s/ Srinivas Akkaraju By Samsara BioCapital GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member 0001699737
Samsara BioCapital GP, LLC 2.6% 707,114 0 707,114 /s/ Srinivas Akkaraju By Srinivas Akkaraju, Managing Member 0001888829
Srinivas Akkaraju 2.6% 707,114 0 707,114 /s/ Srinivas Akkaraju Srinivas Akkaraju 0001253170